Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here is one value stock offering a compelling risk-reward profile and two facing an uphill battle.
Two Value Stocks to Sell:
Charter (CHTR)
Forward P/E Ratio: 3.1x
Operating as Spectrum, Charter (NASDAQ: CHTR) is a leading telecommunications company offering cable television, high-speed internet, and voice services across the United States.
Why Are We Out on CHTR?
- Demand for its offerings was relatively low as its number of internet subscribers has underwhelmed
- Free cash flow margin is anticipated to expand by 2 percentage points over the next year, providing additional flexibility for investments and share buybacks/dividends
- Stagnant returns on capital show management has failed to improve the company’s business quality
Charter’s stock price of $136.85 implies a valuation ratio of 3.1x forward P/E. To fully understand why you should be careful with CHTR, check out our full research report (it’s free).
Avnet (AVT)
Forward P/E Ratio: 11.5x
With a century-long history of adapting to technological evolution, Avnet (NASDAQ: AVT) is a global electronic components distributor that connects manufacturers of semiconductors and other electronic parts with businesses that need these components.
Why Is AVT Not Exciting?
- Sales were flat over the last two years, indicating it’s failed to expand this cycle
- Sales over the last two years were less profitable as its earnings per share fell by 17.7% annually while its revenue was flat
- Poor free cash flow margin of -0.2% for the last five years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
At $82.19 per share, Avnet trades at 11.5x forward P/E. Check out our free in-depth research report to learn more about why AVT doesn’t pass our bar.
One Value Stock to Buy:
HCA Healthcare (HCA)
Forward P/E Ratio: 12.8x
With roots dating back to 1968 and a network spanning 20 states, HCA Healthcare (NYSE: HCA) operates a network of 190 hospitals and 150+ outpatient facilities providing a full range of medical services across the US and England.
Why Should You Buy HCA?
- Dominant market position is represented by its $76.39 billion in revenue, which creates significant barriers to entry in this highly regulated industry
- Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
HCA Healthcare is trading at $410.41 per share, or 12.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
